Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients

Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients

Aim. To determine the risk factors and diagnostic value of urinary N-terminal probrain natriuretic peptide (NT-proBNP) for verification of heart failure in human immunodeficiency virus (HIV)-infected patientsMaterial and methods. This cross-sectional screening clinical trial included 115 HIV-infecte...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. G. Goryacheva, N. A. Koziolova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-03-01
Series:	Российский кардиологический журнал
Subjects:	human immunodeficiency virus heart failure urinary natriuretic peptide
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4853
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Risk factors of severe heart failure in HIV-positive patients
by: O. G. Goryacheva, et al.
Published: (2021-02-01)

ON THE GENETIC REGULATION OF BRAIN NATRIURETIC PEPTIDE LEVEL IN PLASMA OF MEN WITH ESSENTIAL HYPERTENSION
by: I. P. Pashkovа, et al.
Published: (2017-03-01)

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension
by: K. Yu. Nikolaev, et al.
Published: (2023-02-01)

N-terminal Pro-B-Type Natriuretic Peptide is a Myocardial Biomarker in Pulmonary Sepsis and Septic Shock
by: I. N. Tyurin, et al.
Published: (2022-10-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Serum N‐Terminal Pro‐B‐Type Natriuretic Peptide Is Associated With Insulin Resistance in Chinese: Danyang Study
by: Ziwen Zheng, et al.
Published: (2024-11-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Action on elevated natriuretic peptide in primary care: a retrospective cohort study
by: Cornelia JC Vermeer, et al.
Published: (2025-04-01)

Predictive value of brain natriuretic peptide for cardiovascular risk assessment in non-cardiac surgery
by: O. N. Dzhioeva, et al.
Published: (2020-11-01)

EFFECTIVENESS OF PHARMACOTHERAPY FOR NORMALIZATION OF THE BRAIN NATRIURETIC PEPTIDE, RENINE-ANGIOTENSINALDOSTERONE SYSTEM ACTIVATION AFTER SURGICAL REVASCULARIZATION OF MYOCARDIUM IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: S. A. Kovalev, et al.
Published: (2016-12-01)

Heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2020-02-01)

Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure: a prospective cohort study in Vietnam
by: Chau Minh Truong, et al.
Published: (2025-07-01)

CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. Pashchenko, et al.
Published: (2017-09-01)

Increased natriuretic peptides not associated with heart failure
by: A. M. Chaulin, et al.
Published: (2021-01-01)

CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY
by: T. A. Panafidina, et al.
Published: (2017-09-01)

Acute on chronic heart failure—Which variations on B‐type natriuretic peptide levels?
by: Paulo Bettencourt PhD, et al.
Published: (2021-06-01)

Natriuretic peptides as novel regulators of dendritic cells-mediated inflammation
by: Giorgia Manni, et al.
Published: (2025-07-01)

The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct
by: Evgenij G. Furman, et al.
Published: (2019-04-01)

An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
by: WANG Xiao-yu, et al.
Published: (2020-01-01)

Parallels of structural-functional parameters the myocardium, C-type natriuretic peptide and endothelin-1 plasma concentrations in women with uncomplicated essential hypertension
by: V. V. Petrovska, et al.
Published: (2014-12-01)

Evaluation of proinflammatory cytokines and brain natriuretic peptide in patients with rheumatic heart diseases and coronary heart disease complicated by chronic heart insufficiency
by: N A Shoslak, et al.
Published: (2005-04-01)

Contribution of inflammation to heart failure development in human immunodeficiency virus-infected patients
by: N. A. Koziolova, et al.
Published: (2022-03-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

Hyponatremia and brain injury: absence of alterations of serum brain natriuretic peptide and vasopressin Hiponatremia e traumatismo cranioencefálico: ausência de alteração sanguínea do peptídeo natriurético cerebral e hormônio antidiurético
by: Karina Nascimento Costa, et al.
Published: (2009-12-01)

Clinical value of BNP and NT-proBNP for evaluating the cardiac function of patients with chronic renal failure
by: TANG Li, et al.
Published: (2016-01-01)

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN
by: E. N. Arkhipova, et al.
Published: (2012-10-01)

Malnutrition and Muscle Loss Mediate the Association Between NT-proBNP and Mortality in Hospitalized Older Adults
by: Tao J, et al.
Published: (2025-08-01)

Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction
by: Junichi Ohno, et al.
Published: (2025-08-01)

REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
by: A. A. Klimenko, et al.
Published: (2015-09-01)

N-terminal pro-brain natriuretic peptide as a predictive marker of short-term mortality in sepsis
by: Amit Kumar, et al.
Published: (2025-04-01)

Human immunodeficiency virus and anaesthesia
by: M. Khalpey
Published: (2012-06-01)

CHANGES IN THE LEVEL OF NT-proBNP AND MEAN PULMONARY ARTERY PRESSURE FOLLOWING BRONCHOPLASTIC LOBECTOMY OR PNEUMONECTOMY AS MARKERS OF RIGHT VENTRICULAR DYSFUNCTION
by: V. F. Larin, et al.
Published: (2021-03-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Urinary urodilatin levels in patients with renal salt wasting syndrome as a possible new diagnostic marker. A pilot study
by: Vittoriano Della Corte, et al.
Published: (2025-06-01)

Diagnostic value of N-terminal pro-B-type natriuretic peptide in hemodialysis patients
by: D. S. Sedov, et al.
Published: (2020-02-01)

Clinical characteristics of cervical cancer in patients infected with human immunodeficiency virus
by: A. G. Kedrova, et al.
Published: (2023-06-01)

The significance of NT-proBNP decline in the evaluation of heart failure during maintenance hemodialysis
by: LI Ping, et al.
Published: (2019-01-01)